[1]
S. Bitsianis, “The feasibility and effect of intraperitoneal administration of regorafenib on peritoneal carcinomatosis from colorectal cancer in the rat”, Ann Ital Chir, vol. 93, no. 5, pp. 592–598, Sep. 2022.